Discover investment opportunities in Stocks Below 50 Cents using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Below 50 Cents using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Below 50 Cents using our Smart AI Filter.
9 stocks found for "Stocks Below 50 Cents"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.35 | ±93.0% | 2.3 | 0.00% | |||
1.07 | ±100.0% | -0.1 | 0.00% | |||
2.07 | ±100.0% | -4.2 | 0.00% | |||
0.62 | ±100.0% | — | 0.00% | |||
0.45 | ±100.0% | -0.4 | 0.00% | |||
1.43 | ±75.7% | -0.7 | 0.00% | |||
1.24 | ±65.3% | 3.0 | 0.00% | |||
1.90 | ±100.0% | 1.1 | 0.00% | |||
0.51 | ±100.0% | -0.1 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Senseonics (SENS) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Read moreDragonfly Energy Holdings Corp. (DFLI) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $1.29. This compares to a loss of $1.98 per share a year ago.
Read moreWe are initiating coverage of Adaptimmune Therapeutics plc ADAP with a 12-month price target of $3.00, translating into sizeable upside from the stock's current price. Adaptimmune designs, develops, manufactures, and delivers innovative cell therapies via the company's unique T-cell receptor (TCR) platform to treat cancers across multiple solid tumor types.
Read moreQ: What factors should investors consider before investing in TLRY at its current low price?
A: TLRY, a cannabis company, is trading below 50 cents. Investors might consider the volatile cannabis regulatory environment and competitive pressures before investing. Given its low price, some investors see this as a value opportunity, though risks include industry growth projections and financial sustainability.
Q: How does EONR's current valuation reflect its growth potential?
A: Trading below 50 cents, EONR's valuation might suggest market skepticism about its growth prospects. Investors would benefit by examining EONR's revenue trends, market opportunities, and industry developments to assess long-term potential.
Q: What risks are associated with investing in SENS at a low price point?
A: SENS, trading at a low price, poses risks including potential financial instability, market competition, and regulatory challenges in the healthcare sector. Investors should evaluate company fundamentals, cash flow, and product pipeline.
Q: Why might PSTV attract speculative investors despite its low price?
A: PSTV might attract speculative investors due to potential breakthroughs in its biotechnology innovations despite being priced below 50 cents. Keeping an eye on clinical trial results and strategic partnerships is vital for assessing potential gains.
Q: What should investors know about WW's market position amid its low stock price?
A: WW's low stock price may indicate challenges in the highly competitive weight management industry. Investors should explore brand recognition, customer retention strategies, and shifts in health trends impacting WW's market share.
Q: Considering NCNA's price, what are the potential advantages for value investors?
A: NCNA, with a stock price under 50 cents, could appeal to value investors. Advantages include potentially undervalued assets or positive future cash flow prospects, but investors must assess drug approval processes and patent expirations.